Asabys Partners has launched Asabys Innvierte Tech Transfer, a venture capital fund of up to €120 million focused on early-stage life sciences and deep tech companies...
Agomab raised $90 million in Series D funding, led by Asabys, Sanofi, and Invus. Funds will advance clinical trials for its lead fibrosis treatments, including Agmb-129...
Asabys, which counts Alantra as a strategic partner, launched the first fund four years ago with an initial target of €60 million and the support of...